Radiation recall dermatitis induced by tamoxifen during adjuvant breast cancer treatment
- PMID: 25568855
- PMCID: PMC4283001
- DOI: 10.3857/roj.2014.32.4.262
Radiation recall dermatitis induced by tamoxifen during adjuvant breast cancer treatment
Abstract
Tamoxifen and radiotherapy are used in breast cancer treatment worldwide. Radiation recall dermatitis (RRD), induced by tamoxifen, has been rarely reported. Herein, we report a RRD case induced by tamoxifen. A 47-year-old woman had a right quadrantectomy and an axillary lymph node dissection due to breast cancer. The tumor was staged pT2N0; it was hormone receptor positive, and human epidermal growth factor receptor 2 negative. The patient received adjuvant chemotherapy followed by tamoxifen and radiotherapy. After 22 months of tamoxifen, the patient developed a localized heating sensation, tenderness, edema, and redness at the irradiated area of the right breast. The symptoms improved within 1 week without treatment. Three weeks later, however, the patient developed similar symptoms in the same area of the breast. She continued tamoxifen before and during dermatitis, and symptoms resolved within 1 week.
Keywords: Radiation recall dermatitis; Tamoxifen; Treatment.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Kodym E, Kalinska R, Ehringfeld C, Sterbik-Lamina A, Kodym R, Hohenberg G. Frequency of radiation recall dermatitis in adult cancer patients. Onkologie. 2005;28:18–21. - PubMed
-
- Parry BR. Radiation recall induced by tamoxifen. Lancet. 1992;340:49. - PubMed
-
- Singer EA, Warren RD, Pennanen MF, Collins BT, Hayes DF. Tamoxifen-induced radiation recall dermatitis. Breast J. 2004;10:170–171. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources